Nov 7, 2025 7:05 AM Eastern Standard Time Fulgent Reports Third Quarter 2025 Financial Results Share EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent,†or the "Company†), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2025. Third Quarter 2025 Results: Non-GAAP income (loss), non-GAAP income (loss) per share, adjusted EBITDA in ...